Back to Search Start Over

GEP Analyses of Bone Marrow CD34+/Lin-Cells of Chronic Phase CML Patients at Diagnosis Identified Different Sets of Genes Associated to the Molecular Response after 3 and 6 Months of First-Line Nilotinib Treatment